us coin crypto Featured snippets

Low-priced stocks fluctuated strongly, with Shan Ying International, Palm, Xiamen Industrial Co., Huaying Agriculture, Smith Barney, Pubang, Yabo and Jishi Media trading daily.The aquaculture sector oscillated to raise Huaying Agriculture's daily limit, the aquaculture sector oscillated to raise, Huaying Agriculture's daily limit, Tianyu Bio and Chuangye International's previous daily limit, and Zhongshui Fishery, Minhe Shares and Xiaoming Shares followed suit.How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.

Li Dongsheng: The annual benefit of the landing application of TCL AI technology exceeds 540 million yuan. On December 11th, Li Dongsheng, the founder and chairman of TCL, said at the TCL Global Technology Innovation Conference that TCL promoted the landing application of AI technology in high-value scenes such as R&D and manufacturing through long-term development planning, with an annual benefit exceeding 540 million yuan. Yan Xiaolin, CTO of TCL Technology, CTO of TCL Huaxing and Dean of TCL Industrial Research Institute, said that AI has been used to improve the display quality, provide human-computer interaction ability, and also used in intelligent manufacturing. This 540 million yuan is the direct new benefit approved by the financial department and business department of BU (business department), excluding the unclear benefits such as image quality improvement and voice function. (CBN)Wei Shaojun, China Semiconductor Industry Association: We should vigorously develop chip design technology that does not depend on advanced technology. Wei Shaojun, chairman of the Integrated Circuit Design Branch of China Semiconductor Industry Association, said today that with the closure of chip design enterprises in China by external advanced processing resources, the manufacturing technologies that can be used by chip design enterprises in China are no longer as rich as before, and it is necessary to pay attention to the design technology that does not depend on advanced technology in technological innovation. Among them, there are two technical paths worth exploring. One is the innovation of architecture, which has been suggested by the industry that it is the golden age of computer architecture innovation. The second is micro-system integration, and the three-dimensional integration technology evolved from packaging technology is gradually moving towards the foreground. (Reporter Guo Hui)The decline of treasury bond futures expanded, with the 30-year main contract falling by 0.50%, the 30-year main contract falling by 0.50%, the 10-year main contract falling by 0.18%, the 5-year main contract falling by 0.12% and the 2-year main contract falling by 0.05%.

How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.South Korea's KOSPI index rose 1% to 2,442.31.The decline of treasury bond futures expanded, with the 30-year main contract falling by 0.50%, the 30-year main contract falling by 0.50%, the 10-year main contract falling by 0.18%, the 5-year main contract falling by 0.12% and the 2-year main contract falling by 0.05%.